NCT04467060View on ClinicalTrials.gov

A Single Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

August 14, 2014

Primary Completion Date

June 25, 2015

Study Completion Date

June 25, 2015

Conditions
Healthy Male Volunteers
Interventions
DRUG

Anaprazole Sodium

2.5mg, 5mg, 10mg, 20mg, 40mg, 80mg, 120mg, 160mg，fasting oral administration.

DRUG

Placebo

single dose, fasting oral administration

All Listed Sponsors
lead

Sihuan Pharmaceutical Holdings Group Ltd.

INDUSTRY

NCT04467060 - A Single Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects | Biotech Hunter | Biotech Hunter